Unknown

Dataset Information

0

Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures.


ABSTRACT: Cutaneous melanoma could be treated by immunotherapy, which only has limited efficacy on uveal melanoma (UM). UM immunotyping for predicting immunotherapeutic responses and guiding immunotherapy should be better understood. This study identified molecular subtypes and key genetic markers associated with immunotherapy through immunosignature analysis. We screened a 6-immune cell signature simultaneously correlated with UM prognosis. Three immune subtypes (IS) were determined based on the 6-immune cell signature. Overall survival (OS) of IS3 was the longest. Significant differences of linear discriminant analysis (LDA) score were detected among the three IS types. IS3 with the highest LDA score showed a low immunosuppression. IS1 with the lowest LDA score was more immunosuppressive. LDA score was significantly negatively correlated with most immune checkpoint-related genes, and could reflect UM patients' response to anti-PD1 immunotherapy. Weighted correlation network analysis (WGCNA) identified that salmon, purple, yellow modules were related to IS and screened 6 prognostic genes. Patients with high-expressed NME1 and TMEM255A developed poor prognosis, while those with high-expressed BEX5 and ROPN1 had better prognosis. There was no notable difference in OS between patients with high-expressed LRRN1 and ST13 and those with low-expressed LRRN1 and ST13. NME1, TMEM255A, Bex5 and ROPN1 showed potential prognostic significance in UM.

SUBMITTER: Gao G 

PROVIDER: S-EPMC8593069 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures.

Gao Guohong G   Yu Zhilong Z   Zhao Xiaoyan X   Fu Xinyi X   Liu Shengsheng S   Liang Shan S   Deng Aijun A  

Scientific reports 20211115 1


Cutaneous melanoma could be treated by immunotherapy, which only has limited efficacy on uveal melanoma (UM). UM immunotyping for predicting immunotherapeutic responses and guiding immunotherapy should be better understood. This study identified molecular subtypes and key genetic markers associated with immunotherapy through immunosignature analysis. We screened a 6-immune cell signature simultaneously correlated with UM prognosis. Three immune subtypes (IS) were determined based on the 6-immune  ...[more]

Similar Datasets

| S-EPMC9809105 | biostudies-literature
| S-EPMC7668584 | biostudies-literature
| S-EPMC8379639 | biostudies-literature
| S-EPMC9005848 | biostudies-literature
| S-EPMC8187912 | biostudies-literature
| S-EPMC6775505 | biostudies-literature
| S-EPMC6336329 | biostudies-literature
| S-EPMC9468663 | biostudies-literature
| S-EPMC8427429 | biostudies-literature
| S-EPMC8791741 | biostudies-literature